Vernakalant for the Conversion of Atrial Fibrillation: The New Kid On the Block?

ISSN： 1082-720X

Source： Annals of Noninvasive Electrocardiology, Vol.19, Iss.4, 2014-07, pp. : 299-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Vernakalant hydrochloride to treat atrial fibrillation

By Brown Richard A Lau Yee Cheng Lip Gregory YH

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 865-872

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity

By Blomström-Lundqvist Carina Blomström Per

Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. : 671-679

Informa Healthcare

Access to resources Recommend Favorite

Spotlight on Intravenous Vernakalant in Recent-Onset Atrial Fibrillation†

By Duggan Sean T. Scott Lesley J.

Drugs & Aging, Vol. 28, Iss. 6, 2011-06 ,pp. : 501-504

Adis International

Access to resources Recommend Favorite

Intravenous vernakalant: a guide to its use in recent-onset atrial fibrillation

Drugs & Therapy Perspectives, Vol. 27, Iss. 8, 2011-08 ,pp. : 6-10

Adis International

Access to resources Recommend Favorite

Intravenous Vernakalant: A Review of its Use in the Management of Recent-Onset Atrial Fibrillation

By Duggan Sean T. Scott Lesley J.

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 237-252

Adis International

Access to resources Recommend Favorite